Book Now! Book an appointment
Home / News


History of Hyperbaric Therapy

History of Hyperbaric Therapy


Hyperbaric oxygen therapy (HBOT) is a medical treatment that can be traced back to the 1600’s. In 1662, the first renowned chamber was built and operated by a British clergyman named Henshaw. He erected a structure titled, the Domicilium, that was used to treat a variety of conditions. In 1878, Paul Bert, a French physiologist, discovered the link between decompression sickness and nitrogen bubbles. Bert later identified that the pain could be ameliorated with recompression. The concept of treating patients under pressurized conditions was continued by the French surgeon Fontaine, who later built a pressurized mobile operating room in 1879. Fontaine found that inhaled nitrous oxide had a greater potency under pressure, in addition to his patients having improved oxygenation.

In the early 1900’s Dr. Orville Cunningham, a professor of anesthesia, observed that people with particular heart diseases improved better when they lived closer to sea level than those living at higher altitudes. He treated a colleague who was suffering from influenza and was near death due to lung restriction. His resounding success led him to develop what was known as the “Steel Ball Hospital” located along the shore of Lake Erie. The six story structure was erected in 1928 and was 64 feet in diameter. The hospital could reach 3 atmospheres absolute. Unfortunately, due to the depressed financial status of the economy, it was deconstructed during in 1942 for scrap.

Subsequently, hyperbaric chambers were later developed by the military in the 1940’s to treat deep-sea divers who suffered from decompression sickness. In the 1950’s, physicians first employed HBOT during heart and lung surgery, which led to its use for carbon monoxide poisoning in the 1960’s. Since then, over 10,000 clinical trials and case studies have been completed for numerous other health-related applications with the vast majority of results reporting resounding success.

The Science Behind Hyperbaric Therapy

Hyperbaric oxygen therapy (HBOT) is the medical use of oxygen in a pressurized environment, at a level higher than 1 atmosphere absolute (ATA). Increased pressure allows for oxygen to dissolve and saturate the blood plasma (independent of hemoglobin/red blood cells), which yields a broad variety of positive physiological, biochemical and cellular effects. This noninvasive therapy is the most trusted way to increase oxygen levels to all organs of the body. The typical treatment lasts for 60-90 minutes, during which the patient lies down and breathes normally.

HBOT has been demonstrated in several clinical studies to enhance the body’s innate ability to repair and regenerate. It is used as an adjunct therapy to complement and enhance the healing process in both chronic and acute conditions.

It’s like when you purchase a bottle of soda, the CO2 (carbon dioxide) gas bubbles are under pressure, which decreases the size of the bubbles enough that they dissolve into the liquid. Therefore, you are unable to see them. When pressure is released, the volume of each bubble increases and the bubbles appear. While an individual is under pressure, the oxygen molecules decrease in size and are able to dissolve into the blood plasma. This exponentially increases oxygen delivery throughout the body and makes it possible for oxygen to reach inflamed tissue and support optimal cellular and organ functionality.

Aviv Clinics open in Dubai, offers Hyperbaric Therapy for Fibromyalgia Treatment

DUBAI, UAE, June 30, 2021 /PRNewswire/ -- Aviv Clinics, a state-of-the-art Hyperbaric Chamber Clinic, has opened its services in Dubai recently.

The Aviv Medical Program was developed by Dr. Shai Efrati of the Sagol Center for Hyperbaric Medicine and Research at the Shamir Medical Center and his team in Israel.

The clinic plans to offer Hyperbaric Therapy and combat the Fibromyalgia Syndrome (FMS) condition in the country.

What is Fibromyalgia Syndrome?

Fibromyalgia Syndrome (FMS) is a severe condition and is known to affect the lives of 2 to 4 percent of the human population.

The condition is known to affect 9 women for every male human and has been the second most known condition, only behind osteoarthritis, according to primary care doctors.

Fibromyalgia Syndrome is amongst other painful conditions that are caused by a damaged neural network.

Although not hereditary, Fibromyalgia still develops at a frequent pace from environmental stimuli such as diseases, significant injury, or psychosocial circumstances.

Unfortunately, its complex nature makes it hard for researchers to understand the disease's exact cause of occurrence.

What can Hyperbaric Oxygen Therapy do?

Hyperbaric oxygen therapy (HBOT) researchers found evidence supporting the therapy as a legitimate non-pharmaceutical alternative treatment for Fibromyalgia.

FMS does not have a direct impact on a patient's muscles or ligaments; instead, it only affects how neurons send pain signals to the brain.

Because of that, one's pain receptors are significantly lower, making effective therapy a harder process. A lack of physical treatment shows that the most convenient solution is to resort to medications.

Non-prescription medications prove insufficient to offer FM relief. The degree of chronic pain is determined through monitoring the relevant sensors at the source of distress and the reading of that sensory information.

The Canadian Agency for Drugs and Technologies in Health (CADTH) once disclosed through thorough research, that HBOT is a promising pain treatment in patients. Furthermore, they also claimed that HBOT is safer than other methods.

In the clinical study with dynamic response and crossover design, participants were randomly allocated to two groups; treatment or crossover. Individuals in the treatment group were assessed pre-and-post HBOT.

Moreover, the individuals of the crossover-control category are examined three times. Once at the start, once during a no-treatment test cycle, and once after the therapy.

Physical exam, involving sensitivity point count and pain tolerance, detailed assessment of health and wellbeing, and SPECT imaging to evaluate brain activity were all part of the tests.

Numerous studies also show that HBOT can enhance FMS patients' symptoms and improve the standard of living. Furthermore, their findings indicate that HBOT can initiate neuroplasticity and dramatically correct aberrant brain activity within FMS patients' pain-related regions.

HBOT's oxygenation process increases the amount of oxygen for the patient to have better circulation and then transports it to the nervous system.

This process also helps combat conditions like Lyme Disease, which are borne from bacterias thriving in an oxygenated environment. Pumping one's body with high oxygen levels helps combat the threat of such diseases and helps improve one's blood flow and circulation.

Previous studies also showed that HBOT causes neuroplasticity, which fixes persistently damaged brain functions.

It also showed implications that it could lead to better potential outcomes in post-stroke or mild brain injury patients' years after their earlier injury.

These pieces of evidence show that HBOT is a successful, quick, and safe alternative to treat different FM indicators.

To know more about Aviv Clinics and their new Hyperbaric Chamber Therapy treatment, visit their website at


Aviv Clinics Dubai U.A.E

Jumeirah Lake Towers

Tel: +971 800-2848


Cision View original content:

SOURCE Aviv Clinics